Recently, Oprah Winfrey hosted a prime- time special on these medications and the criticism that providers prescribe it too liberally off-label for weight loss.
Weight Watchers, and Noom, long advocates of lifestyle change focusing on diet and exercise have added prescription weight loss drugs approved to treat obesity, such as Wegovy and Ozempic.
Offering the medications within a structured program of diet and exercise, advocates say, increases the chance of long-term success, and acknowledges that obesity is a chronic disease that requires chronic treatment.
While drugs like Wegovy and Ozempic might seem like a miracle to those with diabetes and obesity, the truth is the effects only last while you are taking the medication.
A study published in the Journal for Diabetes, Obesity, and Metabolism in April 2022, which examined changes in body weight and cardiometabolic risk factors upon the termination of the drug, found that after a year people had regained two-thirds of the weight they had lost.
The positive changes they had seen in cardiometabolic risk factors like blood pressure, blood lipids, HbA1c, and C-reactive protein had similarly reversed.